Viskase Holdings Inc (VISK)
Viskase Holdings, Inc. is a common stock listing on OTC Markets. The company currently has no significant operations. In the past, it was involved in selling its drug product, PegIntron. The business was originally incorporated in 1981 and adopted the Enzon Pharmaceuticals, Inc. name in December 2002. The company is headquartered in Cranford, New Jersey.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-VISK
|
$4.81
|
13.1% Upside
|
Fair
|
Not available
|
Not available
|
Fair
|
0.0%
|
0.3x
|
0.2x
|
60.909 M
|
201.3 M
|
71.9%
|
6.2%
|
1.0
|
121.2%
|
